| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -11.94M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BNTC returned +3.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.1% |
| 1 year | +3.8% |
| 5 years | -80.0% |
| 10 years | -97.1% |
| All-time high | $5,610.00 (Jun 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BNTC would be worth today ›No. Benitec Biopharma Inc. has not paid a dividend in the past 12 months.
Benitec Biopharma Inc. stock trades on NASDAQ under the ticker symbol BNTC.
Benitec Biopharma Inc. is part of the Healthcare sector.
Benitec Biopharma Inc. has a market cap of 463.10M USD, based on the latest quote.
Benitec Biopharma Inc. is expected to report earnings around Sep 22, 2026. That date is an estimate and has not been confirmed by the company.